Royal Bank of Canada
CGON icon

Royal Bank of Canada’s CG Oncology CGON Stock Holding History

Royal Bank of Canada’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$774K Buy
11,439
+1,793
+19% +$102K ﹤0.01% 3823
2025
Q4 		$400K Sell
9,646
-198,366
-95% -$8.21M ﹤0.01% 4337
2025
Q3 		$8.38M Buy
208,012
+182,439
+713% +$5.3M ﹤0.01% 2268
2025
Q2 		$665K Buy
25,573
+25,262
+8,123% +$609K ﹤0.01% 4251
2025
Q1 		$8K Sell
311
-2,871
-90% -$80.8K ﹤0.01% 6215
2024
Q4 		$91K Sell
3,182
-2,434
-43% -$83.3K ﹤0.01% 5385
2024
Q3 		$212K Buy
5,616
+3,427
+157% +$120K ﹤0.01% 4771
2024
Q2 		$69K Buy
2,189
+1,661
+315% +$57.6K ﹤0.01% 5495
2024
Q1 		$23K Buy
+528
New +$21.6K ﹤0.01% 5852

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royal Bank of Canada's CGON Position: Q1 2026 in Review

Royal Bank of Canada increased its CG Oncology (CGON) stake by 19% in Q1 2026, buying an estimated $102K and bringing the position to 11,439 shares worth $774K. The position accounts for ﹤0.01% of the portfolio, ranked #3823.

Royal Bank of Canada first reported a position in CGON in Q1 2024 and has held it in 9 quarters since. The position peaked at $8.38M in Q3 2025. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Royal Bank of Canada held 11,439 shares of CG Oncology worth $774K as of Q1 2026.
  • Royal Bank of Canada bought 1,793 CG Oncology shares in Q1 2026, an estimated $102K.
  • CG Oncology made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3823 holding.
  • Royal Bank of Canada first reported a position in CG Oncology in Q1 2024 and has held it in 9 quarters since.
  • Royal Bank of Canada's CG Oncology position peaked at $8.38M in Q3 2025.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.